Fibrinolytic therapy for parapneumonic empyema during pregnancy

Pneumonia and parapneumonic complicated effusion during pregnancy is uncommon but poses potentially serious risks to both mother and fetus. Enzymatic debridement of the pleural cavity with fibrinolytic agents is a noninvasive option that can facilitate drainage and prevent the need for surgery. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulutas, Hakki, Yekeler, Erdal, Ali Sak, Zafer Hasan, Doru, Ihsan, Kuzucu, Akin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920424/
https://www.ncbi.nlm.nih.gov/pubmed/26057709
http://dx.doi.org/10.1016/j.rmedc.2011.08.005
Descripción
Sumario:Pneumonia and parapneumonic complicated effusion during pregnancy is uncommon but poses potentially serious risks to both mother and fetus. Enzymatic debridement of the pleural cavity with fibrinolytic agents is a noninvasive option that can facilitate drainage and prevent the need for surgery. Herein, we describe the cases of two pregnant women with parapneumonic empyema who were successfully treated with intrapleural fibrinolytic therapy.

Ejemplares similares